38.6c New Delhi, India, Saturday, May 18, 2024
Business

Serum Institute of India files Rs. 100 crore Defamation Case After Volunteer Claims of Falling Sick Due to Vaccine Trial

By DEV KUMAR PATEL      30 November, 2020 06:54 PM      0 Comments
Serum Institute Defamation Case Covid

The Serum Institute of India on Sunday (November 20, 2020) filed a Rs. 100 crore defamation suit against a Chennai-based volunteer who took part in their COVID-19 vaccine trial and alleged that it triggered an adverse reaction and suffer a neurological breakdown after taking a dose.

Serum Institute has partnered with drug manufacturer Astra Zeneca and the University of Oxford to produce the Covishield vaccine in the country. The vaccine is seen as a possible option for many developing countries because of its cheaper price and ability to be transported and stored at normal temperatures.

The volunteer aged 40 years sought Rs. 5 crores from Serum Institute citing side effects of virtual neurological breakdown and impairment of cognitive functions after taking the dose of the Covid shot. However, the Serum Institute denied the allegations and called them “malicious” and “misconceived”. 

He also sent a legal notice to ICMR, DCGI, AstraZeneca, and Oxford University to stop testing, manufacturing, and distributing vaccines. In the legal notice, he claims that he experienced headaches and then endured a seven-day stay in the intensive care unit (ICU). ​

We haven’t received any response from any of the parties to whom we have sent the notice. We will be left with no other option but to go ahead and file a writ petition and get ready for a legal battle,” advocate R. Rajaram, on behalf of the Volunteer said.

In a statement, a Serum Institute spokesperson said that while it sympathized with the volunteer's medical condition there was "absolutely no correlation with the vaccine trial and the medical condition of the volunteer"

Further, it is added that, “The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent,” the statement said. “The volunteer is falsely laying the blame for his medical problems on the Covid vaccine trial. In spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company.”

"It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India will seek damages in excess of 100 crores for the same and will defend such malicious claims," Serum Institute said. 

As per experts, Serum Institute is performing bad moves as they initiated a Counter defamation suit against the Volunteer. 

Bioethics expert Professor Anant Bhan reacted on Twitter saying that the move on Serum Institute’s part is to browbeat the volunteer. "A bad move by Serum to counter-sue. Volunteers participate in studies mostly out for altruistic reasons. In this case, healthy volunteers. If there is an issue about the serious adverse event (SAE), better to engage with the participant to understand their concerns. Rather than try to browbeat them," he said.

The All India Drug Action Network (AIDAN) also added by saying that "This ( the defamation suit) is a blatant attempt of intimidation”.



Share this article:



Leave a feedback about this
TRENDING NEWS

fundamental-right-to-health-includes-consumers-right-to-be-made-aware-of-quality-of-products-sc
Trending Judiciary
Fundamental right to health includes consumers' right to be made aware of quality of products: SC [Read Order]

Right to health includes consumers' right to know product quality. Advertisers must submit self-declarations for ads to ensure transparency and accountability: SC

17 May, 2024 01:43 PM
sc-asks-ed-to-file-response-to-sorens-plea-for-interim-on-may-20
Trending Judiciary
SC asks ED to file response to Soren's plea for interim on May 20

SC asks ED to file a response by May 20 to Hemant Soren's plea for interim bail during Lok Sabha elections, with a hearing scheduled for May 21.

17 May, 2024 06:12 PM

TOP STORIES

indian-courts-this-week-law-street-journals-weekly-round-up-of-sc-hcs-may-6-may-10
Trending Judiciary
Indian Courts this Week: Law Street Journal's Weekly Round-Up of SC & HCs [May 6 - May 10]

Get the latest updates from India's Supreme Court and the High Courts ! Here’s a round up of the week's top legal stories in a quick, easy-to-read summary.

13 May, 2024 10:29 AM
sc-dismisses-union-govt-plea-against-bail-to-maoist-financer-in-case-of-attack-on-police-party-in-jharkhand
Trending Judiciary
SC dismisses Union govt's plea against bail to Maoist financer in case of attack on police party in Jharkhand [Read Judgment]

SC rejects govt's plea against bail for accused in Jharkhand police attack case, citing absence of violated bail conditions.

13 May, 2024 11:33 AM
supreme-court-upholds-gang-rape-conviction-though-victim-turned-hostile
Trending Judiciary
Supreme Court upholds gang rape conviction, though victim turned hostile [Read Judgment]

SC upholds gang rape conviction despite victim's hostility, affirming witness credibility in criminal trials.

13 May, 2024 12:24 PM
sanatana-dharma-remarks-sc-seeks-response-from-up-maha-ktka-bihar-jamp;k-on-udhayanidhis-plea-for-clubbing-firs
Trending Judiciary
Sanatana Dharma remarks SC seeks response from UP, Maha, Ktka, Bihar, J&K on Udhayanidhi's plea for clubbing FIRs

SC seeks response on Udhayanidhi's plea for clubbing FIRs related to his remarks on 'Sanatan Dharma'.

13 May, 2024 12:39 PM

ADVERTISEMENT


Join Group

Signup for Our Newsletter

Get Exclusive access to members only content by email